Cartesian Therapeutics, Inc. (NASDAQ:RNAC) has 66 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Dec, 2025 | 1,366,989 | -788,794 | -36.59% | $9,855,990.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 609,696 | -39,645 | -6.11% | $4,395,908.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 541,228 | 20,506 | 3.94% | $3,902,253.00 |
| 683 Capital Management, LLC | 31 Dec, 2025 | 280,000 | 50,000 | 21.74% | $2,018,800.00 |
| Erste Asset Management GmbH | 31 Dec, 2025 | 271,705 | 11,694 | 4.50% | $1,956,354.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 255,539 | 13,710 | 5.67% | $1,842,696.00 |
| State Street Corp | 31 Dec, 2025 | 198,967 | 1,301 | 0.66% | $1,434,552.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 178,140 | 93,334 | 110.06% | $1,284,388.00 |
| Privium Fund Management B.V. | 31 Dec, 2025 | 172,500 | 172,500 | 0.00% | $1,243,725.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 164,366 | 139,009 | 548.21% | $1,185,079.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 113,092 | 84,954 | 301.92% | $815,393.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Dec, 2025 | 95,799 | 65,798 | 219.32% | $690,711.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 91,278 | 91,278 | 0.00% | $658,114.00 |
| Northern Trust Corp | 31 Dec, 2025 | 87,013 | -4,276 | -4.68% | $627,364.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 79,785 | 9,261 | 13.13% | $575,250.00 |
| GSA CAPITAL PARTNERS LLP | 31 Dec, 2025 | 77,227 | -8,868 | -10.30% | $557.00 |
| UBS Group AG | 31 Dec, 2025 | 67,341 | 57,393 | 576.93% | $485,528.00 |
| Walleye Capital LLC | 31 Dec, 2025 | 43,878 | 43,878 | 0.00% | $316,360.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 41,100 | 41,100 | 0.00% | $296,331.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 33,871 | 33,871 | 0.00% | $244,207.00 |